CIK: 0001833486 · Show all filings
Period: Q4 2025 (← Previous)
Filing Date: Feb 13, 2026
Total Value ($000): $82,794 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Surrozen, Inc. | 1,851,350 (+23.4%) | $41,841 (+116.4%) | 50.5% | $12.06 | — | COM | 86889P109 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | RAPT Therapeutics Inc | 156,270 (-5.9%) | $5,293 (+23.6%) | 6.4% | $19.03 | — | COM | 75382E109 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ORIC | ORIC Pharmaceuticals Inc. | 3,540,777 | $28,964 | 35.0% | $28.69 | -59.9% | COM | 68622P109 |
| TNYA | Tenaya Therapeutics, Inc. | 9,400,290 | $6,693 | 8.1% | $21.49 | -93.7% | COM | 87990A106 |
| RVMD | Revolution Medicines Inc | 46 | $4 | 0.0% | $34.24 | +91.5% | COM | 76155X100 |